Browse the corpus
Walk the Even Hospital Database by book and chapter — the raw source passages that ground Ask, DDx, and the rest.
1 passage
REFERENCES Baldwin JR, Fleishaker JC, Azie NE, et al, "A Comparison of the Pharmacokinetics and Tolerability of the Anti-migraine Compound Almotriptan in Healthy Adolescents and Adults," Cephalalgia , 2004, 24(4):288-92. [PubMed 15030538 ] Berenson F, Vasconcellos E, Pakalnis A, et al, "Long-Term, Open-Label Safety Study of Oral Almotriptan 12.5 mg for the Acute Treatment of Migraine in Adolescents," Headache , 2010, 50(5):795-807. [PubMed 20546320 ] Linder SL, Mathew NT, Cady RK, et al, "Efficacy and Tolerability of Almotriptan in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial," Headache , 2008, 48(9):1326-36. [PubMed 18484981 ] McEnroe JD and Fleishaker JC, "Clinical Pharmacokinetics of Almotriptan, a Serotonin 5-HT(1B/1D) Receptor Agonist for the Treatment of Migraine," Clin Pharmacokinet , 2005, 44(3):237-46. [PubMed 15762767 ] Topic 15939 Version 20.0 © 2013 UpToDate, Inc. All rights reserved. | Subscription and License Agreement | Release: 21.4 - C21.36 Licensed to: Southeast Alabama Med Ctr | Support Tag: [1103-201.65.114.212-CC23815824-S244013.14]